Pharmacy Podcast Network

March Madness inspired us, and our audience has waited long enough. What better time, than during a pandemic, to dive into “OPIOID MADNESS” and crown “The Greatest Opioid of All Time”!!! In this episode of the “PAIN POD”, Mark “Pain Guy” Garofoli will continue the conversation from Opioid Madness Part 1, the opioid bracketology, or perhaps an “Opioidology”, but definitely a whole bunch of “Opioid Madness”. The battle of poppy versus poppy, and of course a bunch of man-made opioid opponents as well. Cool names and fancy formulations only get one so far, and we simply have no room for bias, thus pharmacology will rule as law of the land, to ultimately crown, “THE GREATEST OPIOID OF ALL TIME”. The blood thirsty, constipating, yet definitely not sedating championship opioid brawl continues. One opioid, an opioid of all opioids, will remain standing atop the mountain of Mu, declaring its victory over all other opioids from all lands near and far. Which opioid will it be? The PAIN POD crowns the champ! See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

Alzheimer's Disease and Related Dementias are a terrible disease on individuals, caregivers, and communities. There are no cures. However, new data has come out discussing the risk factors, polypharmacy, and a potential early detection opportunity. It's time to de-prescribe and follow the money. Reference: Nicholas LH, Langa KM, Bynum JPW, Hsu JW. Financial Presentation of Alzheimer Disease and Related Dementias. JAMA Intern Med. 2021;181(2):220–227. doi:10.1001/jamainternmed.2020.6432 Maust DT, Strominger J, Kim HM, et al. Prevalence of Central Nervous System–Active Polypharmacy Among Older Adults With Dementia in the US. JAMA. 2021;325(10):952–961. doi:10.1001/jama.2021.1195 CPE details for GameChangers Podcast April 2021 Learning Objective: Discuss if adverse financial outcomes may be a risk factor for future dementia diagnosis. 0107-0000-21-158-H01-P 0.2 CEU/2 Hrs (Knowledge) Initial Release Date: 04/06/21 Expiration Date: 03/02/24 Additional CPE information is located at https://www.ceimpact.com/podcast  Disclosure: Dr. Galdo is a member of the Board of Directors for the Alabama Chapter of the Alzheimer's Association. See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

Dr. Victoria Reinhartz PharmD is an Assistant Professor of Pharmacy Practice at LECOM School of Pharmacy and the Founder & CEO of Mobile Health Consultants, Inc. She also serves as the Consultant Pharmacist for the Manatee County Community Paramedicine Program in Bradenton, FL. Within this role, Dr. Reinhartz and her team resolve medication issues or disease factors which are contributing to frequent 911 use, ER visits, or hospitalization. Dr. Reinhartz's clinical impact has been recognized with a Chief’s Commendation Award and a Congressional EMS Unit Citation Award for exceptional care provision and leadership within EMS. Dr. Reinhartz has also garnered national attention from the United States Public Health Service for collaborative innovation improving community health outcomes. Most recently, she was named the 2020 Next-Generation Pharmacist Civic Leader, for implementing a vision of interprofessional care that spotlights the needs of underserved communities. She is an advocate of Mobile Integrated Health, Community Paramedicine, and interprofessional collaboration with Emergency Medical Services.  What public health means to Dr. Reinhartz is embracing interprofessional skillsets to improve access to care, health outcomes, and quality of life for our communities. Social Media LinkedIn - https://www.linkedin.com/in/victoriareinhartz/ Links Next Generation Pharmacist Awards 2020https://nextgenpharmacist.com/pharmacy-times-and-parata-systems-announce-the-2020-next-generation-pharmacist-winners/  Collaboration by emergency medicine pharmacists and prehospital services providers - American Journal of Health-System Pharmacy, Volume 77, Issue 12, 15 June 2020, Pages 918–921 https://academic.oup.com/ajhp/article-abstract/77/12/918/5831519  EMS World Expo Quick Take: How pharmacists improve EMS patient care - A pharmacist can help EMS improve patient outcomes, participate in protocol development, and collaborate on EMS research projects (Nov 2018) - https://www.ems1.com/pharmacology/articles/ems-world-expo-quick-take-how-pharmacists-improve-ems-patient-care-ZcojQQ56JiCN5GfY/ See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

Episode 21: Sandra Leal Sandra Leal, the 166th president of the American Pharmacists Association, was powerfully influenced by her childhood experiences growing up in an Arizona border town – including the pharmacist in nearby Mexico who essentially served as her family’s main health care provider. In this episode, we talk about those formative experiences, and discuss the twin issues dominating pharmacy today: the pandemic, and structural racism in pharmacy. Recorded April 2, 2021. See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

Chapter 2 of 3  Featuring: Allegheny Health Network Pharmacy Services  Medication Safety Technology Pharmacist/ Technician roles Education and training Guests: Laura (McCoy) Mark, PharmD - Vice President, Pharmacy Kimberly (Miller) Mehta, PharmD, MPH, MHA - Pharmacy Director of Medication Safety and Regulatory  Rich Kaplan, PharmD  This podcast series is sponsored by Omnicell.  See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

In this episode, we are joined by Dr. Jordan Smith, Assistant Professor of Clinical Sciences at High Point University and our go-to expert for questions on infectious diseases. We'll discuss the rumors of infertility associated with the mRNA COVID-19 vaccine, and any possible long-term effects of getting vaccinated. This is NOT your physician's podcast. Hosts Shane Garrettson and Cal Vandergrift dive into the pharmacy world with fun, interesting, and downright weird topics! Tune in for NEW episodes, available on Spotify, Apple, Anchor, and more! Check out our Facebook, Twitter, and Instagram pages at Let's Pharmonize to view videos and images relevant to every episode! If you have any questions, comments, or even corrections, e-mail us at pharmonization@gmail.com. PLEASE READ: Shane and Cal are NOT medical professionals. DO NOT USE the information presented in this podcast to aid in your own personal health or medicinal benefit. This is a light-hearted podcast that should not be taken with the same seriousness as your own personal health,A special thanks to Kelly Kerr for creating the music used in the intro and outro. Additional music by FesliyanStudiosAll Rights Reserved See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

LIPA v ESI: Fight for the Right to Be Paid  What happens when a state implements provider fee statutes that are officially approved by CMS but one of the big 3 PBMs still claims exemption? Join guest host Monique Whitney with special guests Randal Johnson, JR Whaley, and MJ Terrebonne as they discuss Louisiana's legal battle with ESI over 10 cents per claim, and the ramifications this could have on state Medicaid programs nationwide. Host:  Monique Whitney, Executive Director, Pharmacists United for Truth & Transparency  Guests:   Randal Johnson, CEO, Louisiana Independent Pharmacies Association  JR Whaley, Legal Counsel, Louisiana Independent Pharmacies Association  MJ Terrebonne, Health Policy Expert & retired Director of Pharmacy, Louisiana Medicaid See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

Learn how health systems can leverage a vibrant, pharmacy-finance partnership to drive successful 340B programs, and allow pharmacy staff more time to focus on patient care. Find out why 340B program management has evolved, the program challenges that health systems still face, and the data and operational complexities that necessitate a cross-functional approach. Guests:                      Eric Iorfido, PharmD, 340B Program Manager, Penn Highlands DuBois, PA Charles Hirner, RPh, Senior Director, Omnicell 340B Operations Host:                          Ken Perez, Vice President, Healthcare Policy and Government Affairs, Omnicell See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

Tennessee Gov. Bill Lee signed HB 786, a comprehensive PBM reform bill that strengthens existing fair pharmacy audit laws, limits PBM adjudication fees, and prohibits a PBM from reimbursing a pharmacy less than it reimburses a PBM-affiliated pharmacy.May 30, 2019 Tennessee SB650 Present law defines "pharmacy benefits manager" (PBM) to mean a person, business, or other entity and any wholly or partially owned subsidiary of the entity, that administers the medication and/or device portion of pharmacy benefits coverage provided by a health insurance plan, subject to certain exceptions. Present law provides detailed requirements for the conduct of an audit of records of a pharmacist or pharmacy by a health insurance plan, a PBM, the state or its political subdivisions, or any other entity representing the same. One such audit requirement is that a clerical or recordkeeping error regarding a required document or record may not, in and of itself, constitute fraud; however, the claims may be subject to recoupment. This bill instead provides that a clerical or recordkeeping error identified during an audit is not prima facie evidence of fraud or intentional misrepresentation and must not be the basis of a recoupment unless the error results in an actual overpayment to the pharmacy or the wrong medication being dispensed to the patient. As under present law, a clerical error will not be subject to criminal penalties without proof of intent to commit fraud.  Shane Reeves is an American businessman, pharmacist and politician who is the State Senator for the 14th District of Tennessee, which is composed of Bedford County, Moore County, Lincoln County, Marshall County, and part of Rutherford County. As a seventh-generation Tennessean, Senator Shane Reeves has spent his life raising a family and opening businesses in middle Tennessee. He understands the importance of family, character, and conservative values to the people in this community. See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices

More and more vaccines are getting authorization in the United States to prevent COVID-19. However, sometimes a vaccine trial is not always effective. But even failure can provide new insights. Learn about the Janssen COVID-19 vaccine and what happened with the recent Hepatitis C vaccine candidate. This podcast was recorded prior to the joint CDC and FDA statement on the Johnson & Johnson/Janssen COVID-19 vaccine on April 13th. On April 13th, 2021, the CDC and FDA issued a joint statement recommending a pause on the use of the Johnson & Johnson/Janssen COVID-19 vaccine until further notice. Click here for the full statement. Reference: Page K, Melia M, Veenhuis R, et al. Randomized Trial of a Vaccine Regimen to Prevent Chronic HCV Infection. N Engl J Med 2021; 384:541-549. DOI: 10.1056/NEJMoa2023345 Fact Sheet for Healthcare Providers Administering Vaccine Emergency Use Authorization of the Janssen COVID-19 Vaccine to Prevent Coronavirus Disease 2019. https://www.fda.gov/media/146304/download  CPE details for GameChangers Podcast April 2021 Learning Objective: Describe the outcomes of a recently published trial on hepatitis C vaccine candidates. 0107-0000-21-158-H01-P 0.2 CEU/2 Hrs (Knowledge) Initial Release Date: 04/06/21 Expiration Date: 03/02/24 Additional CPE information is located at https://www.ceimpact.com/podcast  See omnystudio.com/listener for privacy information. Learn more about your ad choices. Visit megaphone.fm/adchoices